The United Kingdom’s Cost-Benefit Analysis for Mandatory Synthetic Nucleic Acid Screening Webinar

On March 9, 2026, Dr. Paul-Enguerrand Fady presented a webinar to the Public Health Agency of Canada titled The UK’s Cost-Benefit Analysis for Mandatory Synthetic Nucleic Acid Screening. Dr. Fady is a Biosecurity Policy Manager with the United Kingdom’s Centre for Long-Term Resilience. This webinar describes:

• regulatory landscape on synthetic nucleic acid screening in the United Kingdom
• the methodology for the cost-benefit analysis of the implementation of a mandatory synthetic nucleic acid screening policy
• key results and recommendations arising from this assessment

This United Kingdom’s study has high translatability to the Canadian context. The recording, transcript, and presentation for this webinar are available on the PHAC Training Portal: Nucleic Acid Screening | PHAC Training Portal.